_version_ 1783477109768847360
author Olearo, Flaminia
Nguyen, Huyen
Bonnet, Fabrice
Yerly, Sabine
Wandeler, Gilles
Stoeckle, Marcel
Cavassini, Matthias
Scherrer, Alexandra
Costagliola, Dominique
Schmid, Patrick
Günthard, Huldrych F
Bernasconi, Enos
Boeni, Jürg
D’arminio Monforte, Antonella
Zazzi, Maurizio
Rossetti, Barbara
Neau, Didier
Bellecave, Pantxika
Rijnders, Bart
Reiss, Peter
Wit, Ferdinand
Kouyos, Roger
Calmy, Alexandra
author_facet Olearo, Flaminia
Nguyen, Huyen
Bonnet, Fabrice
Yerly, Sabine
Wandeler, Gilles
Stoeckle, Marcel
Cavassini, Matthias
Scherrer, Alexandra
Costagliola, Dominique
Schmid, Patrick
Günthard, Huldrych F
Bernasconi, Enos
Boeni, Jürg
D’arminio Monforte, Antonella
Zazzi, Maurizio
Rossetti, Barbara
Neau, Didier
Bellecave, Pantxika
Rijnders, Bart
Reiss, Peter
Wit, Ferdinand
Kouyos, Roger
Calmy, Alexandra
author_sort Olearo, Flaminia
collection PubMed
description
format Online
Article
Text
id pubmed-6899347
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68993472019-12-12 Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients Olearo, Flaminia Nguyen, Huyen Bonnet, Fabrice Yerly, Sabine Wandeler, Gilles Stoeckle, Marcel Cavassini, Matthias Scherrer, Alexandra Costagliola, Dominique Schmid, Patrick Günthard, Huldrych F Bernasconi, Enos Boeni, Jürg D’arminio Monforte, Antonella Zazzi, Maurizio Rossetti, Barbara Neau, Didier Bellecave, Pantxika Rijnders, Bart Reiss, Peter Wit, Ferdinand Kouyos, Roger Calmy, Alexandra Open Forum Infect Dis Corrigendum Oxford University Press 2019-12-08 /pmc/articles/PMC6899347/ /pubmed/31832485 http://dx.doi.org/10.1093/ofid/ofz500 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Corrigendum
Olearo, Flaminia
Nguyen, Huyen
Bonnet, Fabrice
Yerly, Sabine
Wandeler, Gilles
Stoeckle, Marcel
Cavassini, Matthias
Scherrer, Alexandra
Costagliola, Dominique
Schmid, Patrick
Günthard, Huldrych F
Bernasconi, Enos
Boeni, Jürg
D’arminio Monforte, Antonella
Zazzi, Maurizio
Rossetti, Barbara
Neau, Didier
Bellecave, Pantxika
Rijnders, Bart
Reiss, Peter
Wit, Ferdinand
Kouyos, Roger
Calmy, Alexandra
Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
title Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
title_full Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
title_fullStr Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
title_full_unstemmed Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
title_short Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
title_sort corrigendum to: impact of the m184v/i mutation on the efficacy of abacavir/lamivudine/dolutegravir therapy in hiv treatment-experienced patients
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899347/
https://www.ncbi.nlm.nih.gov/pubmed/31832485
http://dx.doi.org/10.1093/ofid/ofz500
work_keys_str_mv AT olearoflaminia corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT nguyenhuyen corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT bonnetfabrice corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT yerlysabine corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT wandelergilles corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT stoecklemarcel corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT cavassinimatthias corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT scherreralexandra corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT costaglioladominique corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT schmidpatrick corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT gunthardhuldrychf corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT bernasconienos corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT boenijurg corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT darminiomonforteantonella corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT zazzimaurizio corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT rossettibarbara corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT neaudidier corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT bellecavepantxika corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT rijndersbart corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT reisspeter corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT witferdinand corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT kouyosroger corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients
AT calmyalexandra corrigendumtoimpactofthem184vimutationontheefficacyofabacavirlamivudinedolutegravirtherapyinhivtreatmentexperiencedpatients